Use of Checkpoint Inhibitors in Gray Zone Lymphoma.
Rosales YMZ, Mesquita JL, Garcia YDO, Paz FRF, Campos NCB, Leitão JPV, Filho FDR, Filho RVAO, Lemes RPG, Duarte FB.
Rosales YMZ, et al. Among authors: mesquita jl.
Hematol Oncol Stem Cell Ther. 2023 Jan 12;16(1):315-319. doi: 10.1016/j.hemonc.2020.06.001.
Hematol Oncol Stem Cell Ther. 2023.
PMID: 36634274